CorMedix Inc. — Director's Dealing 2010

Apr 1, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2010-03-30

Reporting Person: Gelbfish Gary A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-30	Common Stock, $0.001 par value per share	C	165368	—	Acquired	165368	Direct
2010-03-30	Common Stock, $0.001 par value per share	C	70872	—	Acquired	70872	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-30	8% Convertible Notes	$	C	165368	Disposed		Common Stock, $0.001 par value per share (0)	Direct
2010-03-30	8% Convertible Notes	$	C	70872	Disposed		Common Stock, $0.001 par value per share (0)	Indirect
2010-03-30	Stock option (right to buy)	$3.1250	A	20000	Acquired	2020-03-30	Common Stock, $0.001 par value per share (20000)	Direct

Footnotes

F1: The 8% Convertible Notes, and all accrued interest thereon, automatically converted into shares of common stock at a conversion price of $2.1875 per share upon the consummation of the Company's initial public offering.

F2: Includes 94,496 shares of common stock held jointly by Dr. Gelbfish and his wife and 70,872 shares of common stock held by Dr. Gelbfish as custodian for certain of his children.

F3: Dr. Gelbfish and his wife are trustees of Landmark Charity Foundation.

F4: These options vest as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012.